Physician profile
Jonathan A Abelson
NPI 1730348053
$583.80
in general payments reported to CMS, 2019-2025
9 companies · $32.67 in 2025
The $32.67 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $56.24 · 2021: $26.24 · 2022: $49.76 · 2023: $166 · 2025: $32.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $198.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $170.40 | 2019-2022 | |
| Progenics Pharmaceuticals, INC. | $145.33 | 2023 | Pylarify |
| Blue Earth Diagnostics | $72.16 | 2019-2023 | |
| Novocure INC. | $65.25 | 2019-2020 | |
| Monteris Medical Corporation | $32.67 | 2025 | Neuroblate |
| Boston Scientific Corporation | $27.96 | 2019-2020 | |
| Viewray Technologies INC | $26.66 | 2022 | |
| Visionrt, INC. | $23.68 | 2019 | |
| Elekta, INC. | $19.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Abelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.